These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 36115585)
21. Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms. Bonsib SM; Boils C; Gokden N; Grignon D; Gu X; Higgins JP; Leroy X; McKenney JK; Nasr SH; Phillips C; Sangoi AR; Wilson J; Zhang PL Pathol Res Pract; 2016 Nov; 212(11):972-979. PubMed ID: 27640314 [TBL] [Abstract][Full Text] [Related]
22. Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma. Mehra R; Vats P; Cao X; Su F; Lee ND; Lonigro R; Premkumar K; Trpkov K; McKenney JK; Dhanasekaran SM; Chinnaiyan AM Eur Urol; 2018 Oct; 74(4):483-486. PubMed ID: 29941307 [TBL] [Abstract][Full Text] [Related]
23. Tuberous Sclerosis Complex and the kidneys: what nephrologists need to know. Monich AG; Bissler JJ; Barreto FC J Bras Nefrol; 2024; 46(3):e20240013. PubMed ID: 38991206 [TBL] [Abstract][Full Text] [Related]
24. Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex. Ritter DM; Fessler BK; Ebrahimi-Fakhari D; Wei J; Franz DN; Krueger DA; Trout AT; Towbin AJ Orphanet J Rare Dis; 2022 Mar; 17(1):124. PubMed ID: 35292049 [TBL] [Abstract][Full Text] [Related]
25. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors. Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182 [TBL] [Abstract][Full Text] [Related]
26. Renal Cell Carcinoma Associated With TSC/MTOR Genomic Alterations: An Update on its Expanding Spectrum and an Approach to Clinicopathologic Work-up. Shah RB; Mehra R Adv Anat Pathol; 2024 Mar; 31(2):105-117. PubMed ID: 37899532 [TBL] [Abstract][Full Text] [Related]
27. Human TSC-associated renal angiomyolipoma cells are hypersensitive to ER stress. Siroky BJ; Yin H; Babcock JT; Lu L; Hellmann AR; Dixon BP; Quilliam LA; Bissler JJ Am J Physiol Renal Physiol; 2012 Sep; 303(6):F831-44. PubMed ID: 22791333 [TBL] [Abstract][Full Text] [Related]
28. Whole Exome Sequencing Identifies TSC1/TSC2 Biallelic Loss as the Primary and Sufficient Driver Event for Renal Angiomyolipoma Development. Giannikou K; Malinowska IA; Pugh TJ; Yan R; Tseng YY; Oh C; Kim J; Tyburczy ME; Chekaluk Y; Liu Y; Alesi N; Finlay GA; Wu CL; Signoretti S; Meyerson M; Getz G; Boehm JS; Henske EP; Kwiatkowski DJ PLoS Genet; 2016 Aug; 12(8):e1006242. PubMed ID: 27494029 [TBL] [Abstract][Full Text] [Related]
29. The association of neurodevelopmental abnormalities, congenital heart and renal defects in a tuberous sclerosis complex patient cohort. Robinson J; Uzun O; Loh NR; Harris IR; Woolley TE; Harwood AJ; Gardner JF; Syed YA BMC Med; 2022 Apr; 20(1):123. PubMed ID: 35440050 [TBL] [Abstract][Full Text] [Related]
30. Renal angiomyolipoma bleeding in a patient with TSC2/PKD1 contiguous gene syndrome after 17 years of renal replacement therapy. Furlano M; Barreiro Y; Martí T; Facundo C; Ruiz-García C; DaSilva I; Ayasreh N; Cabrera-López C; Ballarín J; Ars E; Torra R Nefrologia; 2017; 37(1):87-92. PubMed ID: 27595512 [TBL] [Abstract][Full Text] [Related]
31. Renal transplant in a tuberous sclerosis patient with bilateral giant renal angiomyolipomas and concurrent renal carcinoma. Hussain M; Mubarak M; Sultan G; Ahmed E; Yunus M; Salehi MA; Asif M; Anwer Naqvi SA; Rizvi SA Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):318-21. PubMed ID: 23538357 [TBL] [Abstract][Full Text] [Related]
33. The extent of kidney involvement in paediatric tuberous sclerosis complex. Limavady A; Marlais M Pediatr Nephrol; 2024 Oct; 39(10):2927-2937. PubMed ID: 38832977 [TBL] [Abstract][Full Text] [Related]
34. Tuberous sclerosis complex and DNA repair. Habib SL Adv Exp Med Biol; 2010; 685():84-94. PubMed ID: 20687497 [TBL] [Abstract][Full Text] [Related]
35. Identification of a Novel TSC2 c.170G>A Missense Variant: A Case Report and Elaboration on the Yield of Targeted Options against Tuberous Sclerosis Complex Manifestations. Papageorgiou G; Skouteris N; Valavanis C; Stanc GM; Souka E; Charalampakis N Rev Recent Clin Trials; 2023; 18(4):304-312. PubMed ID: 37877150 [TBL] [Abstract][Full Text] [Related]
36. Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database. Boggarapu S; Roberds SL; Nakagawa J; Beresford E Orphanet J Rare Dis; 2022 Sep; 17(1):355. PubMed ID: 36104799 [TBL] [Abstract][Full Text] [Related]
37. Treatment of renal angiomyolipoma in tuberous sclerosis complex (TSC) patients. Brakemeier S; Bachmann F; Budde K Pediatr Nephrol; 2017 Jul; 32(7):1137-1144. PubMed ID: 27585680 [TBL] [Abstract][Full Text] [Related]
38. Renal organoid modeling of tuberous sclerosis complex reveals lesion features arise from diverse developmental processes. Pietrobon A; Yockell-Lelièvre J; Flood TA; Stanford WL Cell Rep; 2022 Jul; 40(1):111048. PubMed ID: 35793620 [TBL] [Abstract][Full Text] [Related]